Cite
HARVARD Citation
Sparano, J. et al. (n.d.). 5BA Prospective trial of endocrine therapy alone in patients with estrogen-receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry. European journal of cancer. pp. S714-. [Online].